Intellia Therapeutics Announces Second Quarter 2026 Financial Results and Business Updates

Go back to Intellia Therapeutics Announces Second Quarter 2026 Financial Results and Business Updates
(NASDAQ: NTLA) Delayed: 12.34 -0.4 (3.14%)
Previous Close $12.74    52 Week High $30.40 
Open $12.50    52 Week Low $11.86 
Day High $12.82    P/E N/A 
Day Low $12.23    EPS $0.00 
Volume 2,128,598